{
  "nctId": "NCT02920918",
  "briefTitle": "Treatment of Diabetes in Patients With Systolic Heart Failure",
  "officialTitle": "A Randomized Active-Control Double-Blinded Study to Evaluate the Treatment of Diabetes in Patients With Systolic Heart Failure",
  "protocolDocument": {
    "nctId": "NCT02920918",
    "filename": "Prot_SAP_ICF_000.pdf",
    "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form",
    "date": "2016-12-08",
    "uploadDate": "2019-09-22T17:47",
    "size": 2555143,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02920918/document/Prot_SAP_ICF_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": true
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 36,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-10",
    "completionDate": "2018-09",
    "primaryCompletionDate": "2018-09",
    "firstSubmitDate": "2016-09-22",
    "firstPostDate": "2016-09-30"
  },
  "eligibilityCriteria": {
    "criteria": "Major Inclusion Criteria:\n\n* Symptomatic stable heart failure (New York Heart Association (NYHA) functional classification II-III) with reduced left ventricular ejection fraction (LVEF) ≤40%\n* Peak exercise limited by shortness of breath and associated with a respiratory exchange ratio (RER) \\>1.00 (reflecting maximal aerobic effort);\n* Poorly controlled Type 2 Diabetes Mellitus (T2DM)(HbA1c levels between 7.0% and 10.0% if on a treatment regimen including insulin, or between 6.5% and 10.0% if not on an insulin regimen);\n* Eighteen years of age or older.\n\nMajor Exclusion Criteria:\n\n* Type I diabetes;\n* Open label treatment with Sodium-GLucose coTransporter (SGLT)-2 inhibitors (within the past 3 months);\n* Current treatment with thiazolidinedione (within the past 3 months);\n* Chronic Renal Disease defined as Glomerular Filtration Rate (GFR) \\<50 ml•min-1/1.73m2 according to local laboratory\n* Pregnancy or of child-bearing potential or lactating;\n* Active or recent (within 2 weeks) genital/urinary infection;\n* Concomitant conditions or treatment which would affect completion or interpretation of the study (i.e, physical inability to walk or run on a treadmill\n* Inability to give informed consent.\n\nExclusion criteria specific to the cardiac magnetic resonance (CMR) substudy.\n\n* Estimated GFR \\<60 ml•min-1/1.73m2\n* Implantable cardioverter defibrillator, pacemaker or other implantable metal device not compatible with CMR scanning;\n* Severe claustrophobia, inability to lay flat for up to 60 minutes, or other contraindication to CMR scanning.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change From Baseline Aerobic Exercise Capacity at 12 Weeks",
        "description": "Peak oxygen consumption (VO2) measured by maximal cardiopulmonary exercise test",
        "timeFrame": "baseline and 12 weeks"
      },
      {
        "measure": "Change From Baseline Ventilatory Efficiency at 12 Weeks",
        "description": "Minute ventilation (VE) relative to CO2 production (VCO2) slope measured by cardiopulmonary exercise test",
        "timeFrame": "baseline and 12 weeks"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:32.841Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}